New memory-based hybrid model for middle-term water demand forecasting in irrigated areas

Autor: González Perea, R., Fernández García, I., Camacho Poyato, E., Rodríguez Díaz, J.A.

Publikováno v: In Agricultural Water Management 30 June 2023 284

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmaceutical Validation and Error Detection in the Prescription of Antineoplastics in Oncohaematological Patients

Autor: Garzás-Martín de Almagro, M.C., López-Malo de Molina, M.D., Abellón Ruiz, J., Fernández García, I., Isla Tejera, B.

Publikováno v: In Farmacia Hospitalaria (English Edition) 2008 32(5):286-289

Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.

Autor: Ruiz de Garibay G; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Fernandez-Garcia I; Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA., Mazoyer S; Equipe GENDEV, INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, Université Lyon 1, Université St Etienne, Lyon, France., Leme de Calais F; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK., Ameri P; Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA., Vijayakumar S; Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA., Martinez-Ruiz H; Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA., Damiola F; Department of Biopathology, Pathology Research Platform, Centre Léon Bérard, Lyon, France., Barjhoux L; Department of Biopathology, Pathology Research Platform, Centre Léon Bérard, Lyon, France., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Andersen LVB; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Herranz C; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Mateo F; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Palomero L; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Espín R; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Gómez A; Gene Regulation, Stem Cells and Cancer, Center for Genomic Regulation (CRG), Barcelona, Catalonia, Spain., García N; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Jimenez D; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Bonifaci N; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Extremera AI; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain., Castaño J; Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), L'Hospitalet del Llobregat, Barcelona, Spain., Raya A; Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), L'Hospitalet del Llobregat, Barcelona, Spain.; Centre for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.; Catalan Institution for Research and Advanced Studies, Barcelona, Spain., Eyras E; Catalan Institution for Research and Advanced Studies, Barcelona, Spain.; Department of Genome Sciences, The John Curtin School of Medical Research, EMBL Australia Partner Laboratory Network, Australian National University, Canberra, Australia., Puente XS; Department of Biochemistry and Molecular Biology, University Institute of Oncology, University of Oviedo, Oviedo, Spain.; Biomedical Research Centre in Cancer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, and Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain., Lázaro C; Biomedical Research Centre in Cancer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, and Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Barnes DR; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Antoniou AC; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Spurdle AB; Genetics and Computational Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., de la Hoya M; Biomedical Research Centre in Cancer (CIBERONC), Instituto Salud Carlos III, Madrid, Spain.; Molecular Oncology Laboratory, Hospital Clínico San Carlos, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Baralle D; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.; Wessex Clinical Genetics Service, Southampton University Hospital NHS Trust, Southampton, UK., Barcellos-Hoff MH; Department of Radiation Oncology, New York University School of Medicine, New York, New York, USA.; Department of Radiation Oncology, School of Medicine, University of California San Francisco, San Francisco, California, USA., Pujana MA; ProCURE, Oncobell, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Catalonia, Spain.

Publikováno v: Human mutation [Hum Mutat] 2021 Nov; Vol. 42 (11), pp. 1488-1502. Date of Electronic Publication: 2021 Aug 31.

Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy.

Autor: Ma L; Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Gonzalez-Junca A; Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Zheng Y; Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Ouyang H; Department of Radiation Oncology, New York University School of Medicine, New York, New York., Illa-Bochaca I; Department of Radiation Oncology, New York University School of Medicine, New York, New York., Horst KC; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California., Krings G; Department of Pathology, University of California, San Francisco, San Francisco, California., Wang Y; Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Fernandez-Garcia I; Department of Radiation Oncology, New York University School of Medicine, New York, New York., Chou W; Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Barcellos-Hoff MH; Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. MaryHelen.Barcellos-Hoff@ucsf.edu.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Mar 15; Vol. 27 (6), pp. 1778-1791. Date of Electronic Publication: 2021 Jan 05.